Female Reproductive System Adnexal Neoplasm

Female Reproductive System Adnexal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,477 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 651–700 of 1,319 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02764333	TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer	completed	Phase 2	29	Memorial Sloan Kettering Cancer CenterOTHER	1	Nov 30, 2021	clinicaltrials
NCT01312389	A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer	terminated	Phase 1 / Phase 2	3	Abramson Cancer Center at Penn MedicineOTHER	1